Intrahepatic cholangiocarcinoma presenting as Budd-Chiari syndrome: A case report and literature review

Canadian Journal of Gastroenterology

Volumn 19, Issue 12, 2005, Pages 723-728

  Law, Joanna K ^a   Davis, Jenny ^a   Buckley, Anne ^a   Salh, Baljinder ^a,b  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Budd Chiari; Intrahepatic cholangiocarcinoma; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FRESH FROZEN PLASMA; HEPARIN; LACTATE DEHYDROGENASE; OXYGEN; VITAMIN K GROUP;

ABDOMINAL DISTENSION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTICOAGULATION; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPSY; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; BLOOD GAS ANALYSIS; BUDD CHIARI SYNDROME; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPNEA; FATIGUE; GENERAL CONDITION DETERIORATION; HEART ATRIUM THROMBOSIS; HEMATOCHEZIA; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HYPERKALEMIA; ILIAC VEIN; INTENSIVE CARE UNIT; INTRAHEPATIC BILE DUCT; INTUBATION; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NAUSEA; OXYGEN THERAPY; PALLIATIVE THERAPY; PNEUMONIA; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SUPERIOR CAVA VEIN; TACHYCARDIA; THROMBOCYTOPENIA; VEIN THROMBOSIS;

EID: 31144474742     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/943269     Document Type: Article

References (36)

1. Chu KM, Lai EC, Al-Hadeedi S, et al. Intrahepatic cholangiocarcinoma. World J Surg 1997;21:301-5.
2. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004;350:578-85.
3. De BK, De KK, Sen S, et al. Etiology based prevalence of Budd-Chiari syndrome in eastern India. J Assoc Physicians India 2000;48:800-3.
4. Bandyopadhyay SK, Sarkar N, Ghosh S, Dasgupta S. Cholangiocarcinoma presenting with recurrent venous thrombosis. J Assoc Physicians India 2003;51:824-5.
5. Taylor-Robinson SD, Toledano MB, Arora S, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001;48:816-820.
6. Wood R, Brewster DH, Fraser LA, Brown H, Hayes PC, Garden OJ. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer 2003;39:2087-92.
7. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: A true increase? J Hepatol 2004;40:472-7.
8. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004;66:167-79.
9. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-25.
10. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar and distal tumours. Ann Surg 1996;224:463-73.
11. Singh V, Sinha SK, Nain CK, et al. Budd-Chiari syndrome: Our experience of 71 patients. J Gastroenterol Hepatol 2000;15:550-4.
12. Okuda H, Yamagata H, Obata H, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 1995;22:1-9.
13. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: Consensus and controversies. Hepatology 2003;38:793-803.
14. Rakela J, Lange SM, Ludwig J, Baldus WP. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 1985;60:289-92.
15. Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatitic failure by multivariate analysis. Dig Dis Sci 1998;43:1311-6.
16. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome. Hepatology 1996;23:1448-55.
17. Byron D, Minuk GY. Clinical hepatology: Profile of an urban, hospital-based practice. Hepatology 1996;24:813-5.
18. Vilgrain V, Lewin M, Vons C, et al. Hepatic nodules in Budd-Chiari syndrome: Imaging features. Radiology 1999;210:443-50.
19. Sasaki A, Kawano K, Aramaki M, Ohno T, Tahara K, Kitano S. Correlation between tumour size and mode of spread in mass-forming intrahepatic cholangiocarcinoma. Hepatogastroenterology 2004;51:224-8.
20. Yamasaki S. Intrahepatic cholangiocarcinoma: Macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003;10:288-91.
21. Itamoto T, Asahara T, Katayama K, et al. Hepatic resection for intrahepatic cholangiocarcinoma: Relation to gross tumour morphology. Hepatogastroenterology 2001;48:1129-33.
22. Sasaki A, Aramaki M, Kawano K, et al. Intrahepatic peripheral cholangiocarcinoma: Mode of spread and choice of surgical treatment. Br J Surg 1998;85:1206-9.
23. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999;6:108-16.
24. Ohtuska M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525-31.
25. Terada T, Makimoto K, Terayama N, Suzuki Y, Nakanuma Y. Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. J Hepatol 1996;24:706-12.
26. Nakanuma Y, Harada K, Ishikawa A, Zen Y, Sasaki M. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003;10:265-81.
27. Akahane T, Ishii M, Ohtani H, Nagura H, Toyota T. Stromal expression of urokinase-type plasminogen activator receptor (uPAR) is associated with invasive growth in primary liver cancer. Liver 1998;18:414-9.
28. Heimbach JK, Haddock MG, Alberts SR, et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl 2004;10:S65-8.
29. Sharma MP, Ahuja V. Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: A clinician's perspective. Trop Gastroenterol. 1999;20:167-9.
30. Bloom CM, Langer B, Wilson SR. Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 1999;19:1199-218.
31. Valls C, Guma A, Puig I, et al. Intrahepatic peripheral cholangio-carcinoma: CT evaluation. Abdom Imaging 2000;25:490-6.
32. Tillich M, Mischinger HJ, Preisegger KH, Rabl H, Szolar DH. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR Am J Roentgenol 1998;171:651-8.
33. Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 2004;24:155-64.
34. Guibaud L, Bret PM, Reinhold C, Atri M, Barkun AN. Bile duct obstruction and choledocholithiasis: Diagnosis with MR cholangiography. Radiology 1995;197:109-15.
35. Sugiyama M, Hagi H, Atomi Y, Saito M. Diagnosis of portal venous invasion by pancreatobiliary carcinoma: Value of endoscopic ultrasonography. Abdom Imaging 1997;22:434-8.
36. Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document. Gut 2002;51(Suppl 6):VI1-9.